Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Biosci Rep ; 43(3)2023 03 29.
Article in English | MEDLINE | ID: covidwho-2248627

ABSTRACT

Severe coronavirus disease 2019 (COVID-19) infection can lead to extensive lung infiltrate, a significant increase in the respiratory rate, and respiratory failure, which can affect the acid-base balance. No research in the Middle East has previously examined acid-base imbalance in COVID-19 patients. The present study aimed to describe the acid-base imbalance in hospitalized COVID-19 patients, determine its causes, and assess its impact on mortality in a Jordanian hospital. The study divided patients into 11 groups based on arterial blood gas data. Patients in normal group were defined as having a pH of 7.35-7.45, PaCO2 of 35-45 mmHg, and HCO3- of 21-27 mEq/L. Other patients were divided into 10 additional groups: mixed acidosis and alkalosis, respiratory and metabolic acidosis with or without compensation, and respiratory and metabolic alkalosis with or without compensation. This is the first study to categorize patients in this way. The results showed that acid-base imbalance was a significant risk factor for mortality (P<0.0001). Mixed acidosis nearly quadruples the risk of death when compared with those with normal levels (OR = 3.61, P=0.05). Furthermore, the risk of death was twice as high (OR = 2) for metabolic acidosis with respiratory compensation (P=0.002), respiratory alkalosis with metabolic compensation (P=0.002), or respiratory acidosis with no compensation (P=0.002). In conclusion, acid-base abnormalities, particularly mixed metabolic and respiratory acidosis, were associated with increased mortality in hospitalized COVID-19 patients. Clinicians should be aware of the significance of these abnormalities and address their underlying causes.


Subject(s)
Acid-Base Imbalance , Acidosis, Respiratory , Acidosis , Alkalosis , COVID-19 , Humans , Acidosis, Respiratory/metabolism , Acid-Base Imbalance/metabolism , Alkalosis/metabolism , Acidosis/metabolism , Risk Factors
2.
Intern Emerg Med ; 16(7): 1945-1950, 2021 10.
Article in English | MEDLINE | ID: covidwho-1041698

ABSTRACT

In patients visiting the emergency department (ED), a potential association between electrolytes disturbance and coronavirus disease 2019 (COVID-19) has not been well studied. We aim to describe electrolyte disturbance and explore risk factors for COVID-19 infection in patients visiting the ED. We carried out a case-control study in three hospitals in France, including adult ED inpatients (≥ 18 years old). A total of 594 ED case patients in whom infection with COVID-19 was confirmed, were matched to 594 non-COVID-19 ED patients (controls) from the same period, according to sex and age. Hyponatremia was defined by a sodium of less than 135 mmol/L (reference range 135-145 mmol/L), hypokalemia by a potassium of less than 3.5 mmol/L (reference range 3.5-5.0 mmol/L), and hypochloremia by a chloride of less than 95 mmol/L (reference range 98-108 mmol/L). Among both case patients and controls, the median (IQR) age was 65 years (IQR 51-76), and 44% were women. Hyponatremia was more common among case patients than among controls, as was hypokalemia and hypochloremia. Based on the results of the multivariate logistic regression, hyponatremia, and hypokalemia were associated with COVID-19 among case patients overall, with an adjusted odds ratio of 1.89 [95% CI 1.24-2.89] for hyponatremia and 1.76 [95% CI 1.20-2.60] for hypokalemia. Hyponatremia and hypokalemia are independently associated with COVID-19 infection in adults visiting the ED, and could act as surrogate biomarkers for the emergency physician in suspected COVID-19 patients.


Subject(s)
Acid-Base Imbalance/metabolism , COVID-19/metabolism , Emergency Service, Hospital , Severity of Illness Index , Water-Electrolyte Imbalance/metabolism , Acid-Base Imbalance/complications , Adult , Aged , COVID-19/complications , Case-Control Studies , Electrolytes , Female , Humans , Hypokalemia/metabolism , Hyponatremia/metabolism , Male , Middle Aged , Risk Factors , Water-Electrolyte Imbalance/complications
3.
Biochem Pharmacol ; 183: 114278, 2021 01.
Article in English | MEDLINE | ID: covidwho-845710

ABSTRACT

Baking soda and vinegar have been used as home remedies for generations and today we are only a mouse-click away from claims that baking soda, lemon juice, and apple cider vinegar are miracles cures for everything from cancer to COVID-19. Despite these specious claims, the therapeutic value of controlling acid-base balance is indisputable and is the basis of Food and Drug Administration-approved treatments for constipation, epilepsy, metabolic acidosis, and peptic ulcers. In this narrative review, we present evidence in support of the current and potential therapeutic value of countering local and systemic acid-base imbalances, several of which do in fact involve the administration of baking soda (sodium bicarbonate). Furthermore, we discuss the side effects of pharmaceuticals on acid-base balance as well as the influence of acid-base status on the pharmacokinetic properties of drugs. Our review considers all major organ systems as well as information relevant to several clinical specialties such as anesthesiology, infectious disease, oncology, dentistry, and surgery.


Subject(s)
Acid-Base Equilibrium/physiology , Acid-Base Imbalance/metabolism , Acid-Base Imbalance/therapy , Acid-Base Equilibrium/drug effects , Animals , COVID-19/metabolism , COVID-19/therapy , Homeostasis/drug effects , Homeostasis/physiology , Humans , Medicine, Traditional/methods , Medicine, Traditional/trends , Sodium Bicarbonate/administration & dosage , Sodium Bicarbonate/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL